Corindus Vascular Robotics (CVRS) Reports In-Line Q4 EPS

Corindus Vascular Robotics (NYSE: CVRS) reported Q4 EPS of ($0.04), in-line with the analyst estimate of ($0.04). Revenue for the quarter came in at $4.7 million versus the consensus estimate of $4.77 million.

For earnings history and earnings-related data on Corindus Vascular Robotics (CVRS) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• MIND Technology (MIND) Misses Q1 EPS by 5c
• Medtronic completes $550 million Scientia Vascular acquisition